Verve Therapeutics Inc (VERV)

$7.28 -0.55 (-7.02%)
Market Cap 616.35M
Revenue (ttm) 11.76M
Net Income (ttm) -200.07M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,701.28%
Debt to Equity Ratio 0.00
Volume 1,176,600
Avg Vol 1,518,488
Day's Range N/A - N/A
Shares Out 84.66M
Stochastic %K 11%
Beta 1.74
Analysts Strong Sell
Price Target $22.88

Latest News on VERV

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Feb 3, 2025, 4:05 PM EST - 19 days ago

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Kuehn Law Encourages Investors of Verve Therapeutics, Inc. to Contact Law Firm

Jan 31, 2025, 11:11 AM EST - 22 days ago

Kuehn Law Encourages Investors of Verve Therapeutics, Inc. to Contact Law Firm

Verve Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Jan 29, 2025, 7:00 AM EST - 24 days ago

Verve Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Verve Therapeutics, Inc. (VERV) and Encourages Shareholders to Learn More About the Investigation

Jan 26, 2025, 10:00 AM EST - 27 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Verve Therapeutics, Inc. (VERV) and Encourages Shareholders to Learn More About the Investigation

Verve Therapeutics, Inc. (VERV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Jan 22, 2025, 10:00 AM EST - 4 weeks ago

Verve Therapeutics, Inc. (VERV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Verve Therapeutics, Inc. (VERV) Shareholders to Inquire about Securities Investigation

Jan 19, 2025, 10:00 AM EST - 4 weeks ago

Bronstein, Gewirtz & Grossman, LLC Encourages Verve Therapeutics, Inc. (VERV) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Verve Therapeutics, Inc. (VERV) And Encourages Shareholders to Connect

Jan 15, 2025, 10:00 AM EST - 5 weeks ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Verve Therapeutics, Inc. (VERV) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC Encourages Verve Therapeutics, Inc. (VERV) Stockholders to Inquire about Securities Investigation

Jan 12, 2025, 10:00 AM EST - 5 weeks ago

Bronstein, Gewirtz & Grossman, LLC Encourages Verve Therapeutics, Inc. (VERV) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Verve Therapeutics, Inc. (VERV) and Encourages Investors to Learn More About the Investigation

Jan 8, 2025, 10:00 AM EST - 6 weeks ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Verve Therapeutics, Inc. (VERV) and Encourages Investors to Learn More About the Investigation

Verve Therapeutics, Inc. (VERV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Jan 5, 2025, 10:00 AM EST - 6 weeks ago

Verve Therapeutics, Inc. (VERV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Verve Therapeutics, Inc. (VERV) And Encourages Investors to Connect

Jan 2, 2025, 10:00 AM EST - 7 weeks ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Verve Therapeutics, Inc. (VERV) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Is Investigating Verve Therapeutics, Inc. (VERV) And Encourages Stockholders to Connect

Dec 29, 2024, 10:00 AM EST - 7 weeks ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Verve Therapeutics, Inc. (VERV) And Encourages Stockholders to Connect

Verve Therapeutics, Inc. (VERV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Dec 26, 2024, 10:00 AM EST - 2 months ago

Verve Therapeutics, Inc. (VERV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Verve Therapeutics, Inc. (VERV) and Encourages Stockholders to Learn More About the Investigation

Dec 22, 2024, 10:00 AM EST - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Verve Therapeutics, Inc. (VERV) and Encourages Stockholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Verve Therapeutics, Inc. (VERV) Investors to Inquire about Securities Investigation

Dec 18, 2024, 10:00 AM EST - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Verve Therapeutics, Inc. (VERV) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Verve Therapeutics, Inc. (VERV) And Encourages Investors to Reach Out

Dec 15, 2024, 10:00 AM EST - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Verve Therapeutics, Inc. (VERV) And Encourages Investors to Reach Out

DEADLINE APPROACHING: Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm

Oct 27, 2024, 11:00 AM EDT - 4 months ago

DEADLINE APPROACHING: Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Oct 25, 2024, 11:00 AM EDT - 4 months ago

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Verve Therapeutics

Oct 22, 2024, 6:05 PM EDT - 4 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Verve Therapeutics

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Affected Stockholders Are Urged To Reach Out To The Schall Law Firm

Oct 19, 2024, 11:00 AM EDT - 4 months ago

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Affected Stockholders Are Urged To Reach Out To The Schall Law Firm

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm

Oct 17, 2024, 11:00 AM EDT - 4 months ago

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Stockholders Are Urged To Help The Schall Law Firm

Oct 15, 2024, 11:00 AM EDT - 4 months ago

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Stockholders Are Urged To Help The Schall Law Firm

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Reach Out To The Schall Law Firm

Oct 13, 2024, 11:00 AM EDT - 4 months ago

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Reach Out To The Schall Law Firm

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Contact The Schall Law Firm

Oct 11, 2024, 11:00 AM EDT - 4 months ago

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Contact The Schall Law Firm

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Reach Out To The Schall Law Firm

Oct 9, 2024, 11:00 AM EDT - 4 months ago

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Reach Out To The Schall Law Firm

VERV REMINDER – Robbins LLP Urges VERV Investors to Obtain Legal Counsel in Light of the Pending Lead Plaintiff Deadline

Oct 4, 2024, 8:40 PM EDT - 5 months ago

VERV REMINDER – Robbins LLP Urges VERV Investors to Obtain Legal Counsel in Light of the Pending Lead Plaintiff Deadline

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Encouraged To Contact The Schall Law Firm

Oct 1, 2024, 11:00 AM EDT - 5 months ago

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Encouraged To Contact The Schall Law Firm

Investors in Verve Therapeutics, Inc. Should Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights - VERV

Sep 30, 2024, 5:45 AM EDT - 5 months ago

Investors in Verve Therapeutics, Inc. Should Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights - VERV